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Background: The expression of myocardin, a cardiac-restricted gene, increases during environmental stress.
How mechanical stretch affects the regulation of myocardin in vascular smooth muscle cells (VSMCs) is not fully
understood. We identify the mechanisms and pathways through which mechanical stretch induces myocardin
expression in VSMCs.
Results: Rat VSMCs grown on a flexible membrane base were stretched to 20% of maximum elongation, at
60 cycles per min. An in vivo model of aorta-caval shunt in adult rats was also used to investigate myocardin
expression. Cyclic stretch significantly increased myocardin and angiotensin II (AngII) expression after 18 and 6 h
of stretch. Addition of extracellular signal-regulated kinases (ERK) pathway inhibitor (PD98059), ERK small interfering
RNA (siRNA), and AngII receptor blocker (ARB; losartan) before stretch inhibited the expression of myocardin
protein. Gel shift assay showed that myocardin-DNA binding activity increased after stretch. PD98059, ERK siRNA
and ARB abolished the binding activity induced by stretch. Stretch increased while myocardin-mutant plasmid,
PD98059, and ARB abolished the promoter activity. Protein synthesis by measuring [3H]proline incorporation into
the cells increased after cyclic stretch, which represented hypertrophic change of VSMCs. An in vivo model of
aorta-caval shunt also demonstrated increased myocardin protein expression in the aorta. Confocal microscopy
showed increased VSMC size 24 h after cyclic stretch and VSMC hypertrophy after creation of aorta-caval shunt for
3 days.
Conclusions: Cyclic stretch enhanced myocardin expression mediated by AngII through the ERK pathway in
cultured rat VSMCs. These findings suggest that myocardin plays a role in stretch-induced VSMC hypertrophy.
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In recent years, vascular smooth muscle cell (VSMC)
hypertrophy has been increasingly associated with the
development of atherosclerotic disease [1]. Hypertrophy
of VSMCs may result in plaque rupture and vulnerability
in atherosclerosis [2]. Hypertrophy of VSMCs may be
induced by certain cardiac-restricted genes through
specific pathways under different types of environmental
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reproduction in any medium, provided the orMyocardin is a potent cardiovascular regulated gene
and transcriptional cofactor, which functionally synergizes
with serum response factor (SRF; a transcriptional factor)
and has been documented to have measurable effects on
cardiac embryo development and both VSMC and cardio-
myocyte hypertrophy [6-10]. An earlier study showed
myocardin knockout mice resulted in embryonic lethality
at E10.5, and was associated with failed VSMC differen-
tiation [7]. Previous studies performed on rat carotid ar-
tery VSMCs following vascular injury have demonstrated
that myocardin can selectively regulate SRF binding to the
degenerate CArGs on VSMC actin to increase transcrip-
tional activity. Loss of myocardin may contribute to the
supression of actin expression in response to vascular
injury. Vascular injury has been associated with inducedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with dominant-negative forms and small interfering
RNA (siRNA) of myocardin in cultured VSMC de-
creased transcription of VSMC maker genes. Previous
reports also indicated that either exogenous addition or
stress-induced expression of angiotensin II (AngII) se-
cretions would result in myocardin expression and sub-
sequent VSMC or cardiac myocyte hypertrophy [12-15].
So myocardin itself may act as a cardiac regulated gene
and cooperate with AngII in regulating VSMC or/and
cardiac myocyte hypertrophy through specific signal
transduction pathways under conditions of stress or
injury to the cardiovascular system.
The application of cyclic stretch to cultured VSMCs has
been widely used as an in vitro experiment to study mo-
lecular events in response to mechanical overload [16-20].
It has previously been reported that cyclic mechanical
stretch induced hypertrophy in VSMCs [21-24]. Cells in
the cardiovascular system are permanently subjected to
mechanical forces due to the pulsatile variation of blood
flow and shear force, created by the beating heart. These
hemodynamic forces play an important role in the regula-
tion of vascular development, remodeling, repair and for-
mation of atherosclerotic stenosis [25-28]. Mechanical
stretch can modulate several different cellular functions in
VSMCs. These functions may include cell proliferation
and differentiation, migration, survival or apoptosis,
vascular remodeling, as well as autocrine or paracrine
functions [29,30]. This study aimed to identify the cellular
and molecular effects of mechanical stretch on VSMCs
regulated by myocardin, and to identify its signal trans-
duction pathway and relationship with AngII. Knowing
the impact of mechanical stretch on the cardiovascular
system is crucial to the understanding of the pathogenesis
of cardiovascular diseases, and a key to providing new
insight into the prevention and therapy of cardiovascular
diseases.
Previous reports have provided strong evidence that
myocardin plays an important role in VSMC hypertrophy
related to AngII secretion [12]. However, no previous
study has shown how cyclic mechanical stretch affects
myocardin in the hypertrophy of VSMCs. Thus, in this
study, we firstly investigated the mechanism of myocardin
expression in cyclic mechanical stretch. Secondly, we
investigated the effect and signal transduction pathway of
myocardin expression induced by cyclic stretch.
Methods
Vascular smooth muscle cell culture
Primary cultures of VSMC were grown by the explant
technique from the thoracic aorta of 200–250 g male
Sprague–Dawley rats, as previously described [31,32].
Cells were cultured in medium containing 20% fetal calf
serum, 0.1 mmol/L non-essential amino acids, 1 mmol/Lsodium pyruvate, 4 mmol/L L-glutamine, 100 U/mL
penicillin, and 100 mg/mL streptomycin at 37°C under
5% CO2/95% air in a humidified incubator. When
confluent, monolayers of VSMCs were passaged every
6–7 days after trypsinization and were used for experi-
ment from the 4th to 6th passages. These 4th to 6th pas-
sage cells were then cultured in Flexcell I flexible
membrane dishes in medium containing 0.5% fetal calf
serum, and the cells were incubated for a further 2 days
to render them quiescent before initiating each experi-
ment. The study was reviewed and approved by the
Institutional Animal Care and Use Committee of Shin
Kong Wu Ho-Su Memorial Hospital and conforms to
Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No. 85–23, revised 2011).
In vitro cyclic stretch on cultured vascular smooth muscle
cells
The strain unit Flexcell FX-2000 (Flexcell International
Co., NC, USA) consists of a vacuum unit linked to a
valve controlled by a computer program. VSMCs cul-
tured on the flexible membrane base were subjected to
cyclic stretch produced by this computer-controlled
application of sinusoidal negative pressure, as previously
characterized and described in detail [33,34]. A 10% or
20% cyclic stretch was performed with a frequency of
1 Hz (60 cycles/min).Antibodies and reagents
Rabbit polyclonal antibodies against myocardin, mouse
monoclonal antibodies (mAbs) against c-Jun N-terminal
kinase (JNK) and anti-GAPDH antibodies were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse
mAbs against p38 mitogen-activated protein kinase
(MAPK), extracellular signal-regulated kinase (ERK), and
phospho-ERK were purchased from BD Bioscience
Pharmingen (San Diego, CA). PD98059, SB203580, and
SP600125 were purchased from Calbiochem (San Diego,
CA). All other chemicals of reagent grade were obtained
from Sigma (St Louis, MO). The roles of JNK, p38
MAPK, and ERK in stretch-induced myocardin expres-
sion were determined by pretreatment of the VSMCs
with 25 μM SP600125, 3 μM SB203580, or 50 μM
PD98059 for 30 min before cyclic stretch. SP600125 is a
potent, cell-permeable, selective, and reversible inhibi-
tor of JNK. SB203580 is a highly specific, cell-permeable
inhibitor of p38 MAPK. PD98059 is a specific and po-
tent inhibitor of the ERK pathway. The AngII and AngII
antibodies came from Bachem AG (Torrance, CA). To
examine the effect of ARB (AngII type 1 receptor
blocker), VSMCs were treated with 100 nM losartan
(Merck & Co, Inc).
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Western blot was performed as previously described [35].
Real-time RT-PCR
Total RNA was isolated from VSMCs using the single-
step acid guanidinium hiocyanate/phenol/chloroform
extraction method. The cDNA produced by reverse tran-
scription (RT) was used to generate myocardin probes by
polymerase chain reaction (PCR) as previously described
[17]. Primers were designed for detection of myocardin
gene expression. The primers for myocardin were: 5′-GG
ACTGCTCTGGCAACCCAGTGC-3′; reverse: 5′-CATC
TGCTGACTCCGGGTCATTTGC - 3′. GAPDH gene ex-




VSMCs were transfected with 800 ng of ERK- and
myocardin-annealed siRNA (Dharmacon, Lafayette, CO).
ERK siRNAs are target- specific 20- to 25-nt siRNAs
designed to knock down gene expression. The siRNA
sequences were 5′-GACCGGAUGUUAACCUUUAUU
(sense) and 5′-PUAAAGGUUAACA UCCGGUCUU
(antisense) for ERK. The myocardin siRNA sequences
were 5′-UGCAACUGCAGAAGCAGAAUU (sense) and
5′-UGCAACUGGUCUUGCAGAAUU (antisense). As a
negative control, a non-targeting (control) siRNA
(Dharmacon) was used. For transfection of rat VSMCs
with siRNA oligonucleotides, we used Effectene trans-
fection reagent according to the manufacturer’s in-
structions (Qiagen, Valencia, CA). After incubation at
37°C, cells were subjected to stretch and analyzed by
Western blot.
Measurement of AngII concentration by enzyme-linked
immunosorbent assay (ELISA)
Conditioned medium from VSMCs subjected to cyclic
stretch and those from unstretched cells were collected
for AngII measurement. The level of AngII was mea-
sured by a quantitative sandwich enzyme immunoassay
technique (R&D Systems, Minneapolis, MN, USA). The
lowest limit of AngII ELISA kit was 52 pg/mL.
Electrophoretic mobility shift assay (EMSA)
Nuclear protein concentrations from cultured VSMCs
were determined by the Bradford method as commer-
cialized by Santa Cruz Biotechnology and EMSA was
performed as previously described [13]. Consensus and
control oligonucleotides were labeled by polynucleotide
kinase incorporation of [γ-32P] ATP. In each case, mutant
or cold oligonucleotide was used as a control to compete
with the labeled sequences. The oligonucleotide sequence
of consensus binding site for SRF was sense: 5′- GGATGT CCA TAT TAG GAC ATC T-3′ and reverse: 5′-
CCT ACA GGT ATA ATC CTG TAG A-3′. The mutant
oligonucleotide sequence was 5′- GGA TGT CCA TAT
TAT TAC ATC T-3′.
Promoter activity assay
A −968 to +44 bp rat myocardin promoter construct was
generated as previously described [13]. The myocardin
promoter contains myocardin binding sites for SRF
(sequences: CGGTTTAGGG) located at −514 to −505 bp
of the promoter region. We used the binding sites to
detect the transcriptional activity of myocardin. For con-
struction of the mutant SRF binding region of myocardin,
we changed the sequences located at −507 to −506 bp
from CGGTTTAGGG to CGGTTTATTG by using a mu-
tagenesis kit (Stratagene, La Jolla, CA). Site-specific muta-
tions were confirmed by DNA sequencing. Plasmids were
transfected into VSMCs using a low-pressure accelerated
gene gun (Bioware, Taipei, Taiwan). Rat genomic DNA
was amplified with forward (GGACTGCTCTGGCAAC
CCAGT GC) and reverse (CATCTGCTGACTCCGGG
TCATTTGC) primers. The amplified product was di-
gested with Mlu I and Bgl II restriction enzymes and li-
gated into pGL3-basic luciferase plasmid vector (Promega,
Madison, WI) digested with the same enzymes. In brief,
2 μg of plasmid DNA was suspended in 5 mL of PBS and
was delivered to the cultured VSMCs at a helium pressure
of 15 psi. The transfection efficiency using this method is
30%. Following 12 h of cyclic stretching, cell extracts were
prepared using the Dual-Luciferase Reporter Assay System
(Promega) and measured for dual luciferase activity by
luminometer (Turner Designs, Sunnyvale, CA, USA).
Migration assays
The migration activity of VSMCs was determined using
the growth-factor-reduced Matrigel invasion system
(Becton Dickinson), following the protocol provided by
the manufacturer. The migration assay was performed as
previously described [17].
Determination of protein synthesis
Protein synthesis was examined by measuring [3H]proline
incorporation into the cells. Cultured VSMCs were
divided into the following groups: (1) control group: the
cells were cultured in serum-free DMEM; and (2) me-
chanical stretch group (20% cyclic stretch) added to
serum-free medium. Each experiment was repeated 6
times. VSMCs were first grown in DMEM with 10% FBS
and 200 mg/L L-glutamine, and then seeded in 24-well
plates at 1 × 105 cells/well in DMEM+ 10% FBS. After
synchronization of VSMCs, the medium was changed to
DMEM without serum. VSMCs were treated with cyclic
stretch and exposed to [3H]proline at the concentration of
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Figure 1 Cyclic stretch induces myocardin protein and mRNA
expressions in VSMCs. Western blots for myocardin in VSMCs
subjected to cyclic stretch by 10% or 20% (A) for varying periods of
time. VSMCs were kept as control or subjected to cyclic stretch and
their protein (B) and mRNA (C) expressions were determinated by
western blot and quantitative real time PCR analyses, respectively.
Data are shown as mean ± SEM from 5 independent experiments.
*P < 0.01 vs. control.
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PBS and 10% trichloroacetic acid. Acid-insoluble [3H]
proline was collected on glass fiber filters (Whatman,
Kent, UK) and determined by a liquid scintillation coun-
ter (LS 6500, Beckman, Fullerton, CA , USA).
Rat model of aorta-caval shunt
The aorta-caval shunt was produced as previously
described [17]. The vena cava and aorta were exposed via
abdominal midline incision. In brief, the aorta was punc-
tured at the union of the segment two-thirds caudal to the
left renal artery and one-third cephalic to the aortic bifur-
cation, with an 18-gauge disposable needle held with a
plastic syringe. The needle was advanced into the aorta,
perforating its adjacent wall and penetrating the vena cava.
The induced aorta-caval shunt produced a ratio of 1.7 of
pulmonary to systemic flow. Sham-operated control ani-
mals were prepared in a similar manner, except that the
aorta was not punctured.
Statistical analysis
All results were expressed as means ± SEM. Statistical
significance was evaluated using variance (GraphPad
Software Inc., San Diego, CA, USA). Dunnett’s test was
used to compare multiple groups to a single control
group. Tukey-Kramer comparison was used for pairwise
comparisons between multiple groups after ANOVA. A
value of P < 0.05 was considered to denote statistical
significance.
Results
Cyclic stretch enhances myocardin protein and mRNA
expression in vascular smooth muscle cells
The level of myocardin protein began to increase as early
as 6 h after stretch to 20% elongation, reaching a
maximum of 3.1-fold over the control by 18 h, remaining
elevated up to 24 h and tending to decline at 30 h. When
VSMCs were stretched at 10% elongation, the level of
myocardin protein was similar to that of controls without
stretch (Figure 1A and B). The real-time PCR showed that
myocardin mRNA expression increased maximally after
18 h of stretch at 20% elongation (Figure 1C). These
results indicated that cyclic stretch induced myocardin
expression in VSMCs.
Stretch-induced myocardin protein expression in vascular
smooth muscle cells is mediated by the ERK pathway
To identify the possible signal pathway mediating the
stretch-induced myocardin expression in VSMCs, the
VSMCs were stretched 20% for 24 h in the presence and
absence of inhibitors or siRNA. As shown in Figure 2, the
stretch-induced increases of myocardin proteins were sig-
nificantly blocked when PD98059 (ERK pathway inhibitor;
50 μM) and ERK siRNA were added 30 min beforestretch. The myocardin proteins induced by stretch were
not affected by the addition of SP600125 (20 μM) or
SB203580 (30 μM). To test the specific effect of ERK
MAPK (Mitogen-Activated Protein Kinase) pathway on
mediating the expression of myocardin, ERK siRNA was
transfected to VSMCs before cyclic stretch. Moreover,
ERK siRNA also completely blocked the myocardin
expression induced by stretch (Figure 2B). The DMSO
(Dimethyl sulfoxide) alone as a vehicle control and control
siRNA did not affect the myocardin expression induced
by cyclic stretch. These findings implied that the ERK
pathway, but not JNK or p42/p44 MAP kinases, mediated
the induction of myocardin proteins by stretch in VSMCs.
The conditioned medium from stretched VSMCs could
induce the same increase in myocardin protein expression
in non-stretched VSMCs (Figure 2A and B). These fin-
dings suggest that cyclic stretch regulated myocardin





































*                  #    #                 *












































D *     *     *      *      #
Figure 2 Cyclic stretch-induced myocardin expression is mediated by the ERK pathway. (A and B) ERK pathway inhibitor (PD98059) and
ERK siRNA knocked down total ERK protein expression. (A) Western blots for myocardin protein in VSMCs subjected to cyclic stretch in the
absence or presence of inhibitors, siRNA, and vehicle (DMSO; Dimethyl sulfoxide 0.1%). CM = conditioned medium. (B) Quantitative analysis of
myocardin protein levels. The values from stretched VSMCs have been normalized to values in control cells (n = 5 per group). *P < 0.01 vs. control.
(C and D) Phosphorylation of ERK mediated stretch-induced myocardin expression, which was blocked by PD98059. Rat VSMCs were subjected to
stretch for different periods of time in the presence or absence of inhibitors, and cell lysates were collected for western blot analysis using
antibodies for total and phospho-ERK. T-ERK = total ERK. P-ERK = ERK phosphorylation. *P < 0.01 vs. control. #P < 0.01 vs. 18 h; (n = 3).
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protein in rat vascular smooth muscle cells
We also found that ERK protein phosphorylation in-
creased to its maximal level 24 h after 20% cyclic stretch
and declined gradually. The ERK pathway inhibitor
(PD98059) could effectively block the phosphorylation of
ERK protein (Figure 2C and D).
Cyclic stretch stimulates secretion of angiotensin II from
vascular smooth muscle cells
As shown in Figure 3A, cyclic stretch significantly began
to increase the AngII secretion from VSMCs and reached
a peak at 6 h after stretch. Later, AngII levels declined
gradually until 30 h (Figure 3A). Myocardin protein
expression induced by cyclic stretch could effectively
suppressed by AngII antibodies (Figure 3B and C). These
results indicated that stretch causes VSMCs to secrete
AngII.
Exogenous addition of angiotensin II increases myocardin
protein expression
To investigate the direct effect of AngII on myocardin
expression in VSMCs, AngII at different concentrationswas administered to the cultured medium for 24 h. As
shown in Figure 3B and C, the effect of AngII on
myocardin protein expression was dose-dependent. These
findings suggested that exogenous addition of AngII also
enhances myocardin expression without cyclic stretch.
Addition of losartan 30 min before stretch significantly
blocked the expression of myocardin induced by cyclic
stretch for 24 h.
Cyclic stretch increases myocardin binding activity
Cyclic stretch of VSMCs for 6–18 h significantly increased
the DNA-protein binding activity of myocardin to SRF
(Figure 4A). An excess of unlabelled myocardin oligo-
nucleotide competed with the probe for binding myocardin
protein, whereas an oligonucleotide containing a 2 bp sub-
stitution in the myocardin binding site did not compete for
binding. Addition of ARB (losartan) and ERK pathway in-
hibitor (PD98059) 30 min before stretch abolished the
DNA-protein binding activity induced by cyclic stretch.
Exogenous administration of AngII to the VSMCs without
stretch also increased myocardin-DNA binding activity
(Figure 4A). These results demonstrated that stretch
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Figure 3 AngII mediates stretch-induced myocardin expression in rat VSMCs. (A) AngII was measured in the culture medium by a
quantitative, competitive ELISA, using a specific anti-AngII antibody. AngII levels increased significantly 6 h after 20% stretch. (B and C) Either
20% stretch or exogenous addition of AngII increased myocardin expression, and was inhibited by AngII antibodies or ARB (losartan). In this
experiment, Western blots for myocardin protein in VSMCs subjected to cyclic stretch or exogenous addition of AngII in the absence or presence
of inhibitors (AngII Ab or losartan) were performed. GAPDH was shown for equal amounts of protein loading in each lane. *P < 0.01 vs. control.
#P < 0.01 vs. 24 h after stretch or 10 h after exogenous addition of AngII (n = 3).
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through the ERK pathway
To study whether the myocardin expression induced by
stretch is regulated at the transcriptional level, we cloned
the promoter region of rat myocardin (−968 to +44) and
constructed a luciferase reporter plasmid (pGL3-Luc).The myocardin promoter construct contains myocardin
binding sites. As shown in Figure 4B and C, transient
transfection experiments on VSMCs using this reporter
gene revealed that stretch for 6 h significantly induced
myocardin promoter activity. This result indicated






Figure 4 Effects of cyclic stretch on myocardin binding activity
and promoter activity in VSMCs. Binding activity between
myocardin and SRF and genetic transcription activity at SRF binding
site of myocardin promoter increase in VSMCs under 20% cyclic stretch.
(A) EMSA showed increased binding between myocardin and SRF
under 20% cyclic stretch, which was suppressed by losartan and
PD98059. Exogenous addition of AngII (10 nM) without cyclic stretch
also increased the binding between myocardin and SRF. (B and C)
Luciferase reporter assay revealed 20% cyclic stretch increased
transcriptional activity at SRF binding sites of myocardin promoter
when compared with the myocardin mutant, which was suppressed
by PD98059 and losartan. Exogenous addition of AngII (10 nM)
without cyclic stretch also increased the transcriptional activity in
VSMCs. *P< 0.01 vs.control. #P < 0.01 vs. 6 hr (n = 3 per group).
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myocardin binding sites were mutated, the increased
promoter activity induced by stretch was abolished.
Moreover, addition of ERK pathway inhibitor (PD98059)
and ARB (losartan) caused an inhibition of trans-
cription. These results suggested that the binding site
in the myocardin promoter is essential for transcrip-
tional regulation by cyclic stretch. In addition, we also
found that exogenous addition of AngII without
stretch increases the transcriptional activity in VSMCs
(Figure 4C).Myocardin increases the migration of VSMCs
Rat VSMCs cultured in the conditioned medium gene-
rated from stretched cells migrated significantly through
the filter membrane compared with those cultured in
non-conditioned medium (Figure 5A and B). Inhibition of
myocardin activity was observed by ERK pathway inhibi-
tor (PD98059), ARB (losartan), and myocardin siRNA,
which decreased VSMC migration activity (Figure 5A and
B). The migration activity of VSMCs was similar in
controls and scrambled siRNA-treated groups. These fin-
dings suggest that myocardin mediates the migration of
VSMCs induced by cyclic stretch.
Cyclic stretch induces protein synthesis in VSMCs and
VSMC hypertrophy
We evaluated protein synthesis in VSMCs by measuring
[3H]proline incorporation into the cells. Result showed
increased protein synthesis in conditioned medium (CM)
after cyclic stretch for 12 to 24 hr, which represented
hypertrophic change of VSMCs (Figure 6). Pretreatment
with ERK pathway inhibitor (PD98059), losartan, AngII
antibody, and myocardin siRNA inhibited the protein
synthesis induced by cyclic stretch. Exogenous addition of
AngII also increased proline incorporation similar to the
effect of cyclic stretch. We also used confocal microscopy
to identify the effect of VSMC hypertrophy under cyclic
stretch (Figure 7A and B). Confocal microscopy showed
increased VSMC size 24 hr after cyclic stretch, which rep-
resented a hypertrophic change of VSMCs (Figure 7B).
In vivo aorta-caval shunt increases aortic myocardin
protein expression
Aorta-caval shunt was performed to explore whether
myocardin expression increased under volume-overload
in vivo. As shown in Figure 8, the myocardin protein
expression in rat aorta significantly increased at days 1 to
3 after performing of aorta-caval shunt. It reached a ma-
ximum of 3.0-fold over the sham-operated rat and
remained elevated up to 7 days. In addition, treatment
with losartan (10 mg/kg/day; from day 1 to day 5) after
performing aorta-caval shunt signigicantly suppressed
myocardin protein expression (Figure 8C and D). Con-
focal microcopy also revealed VSMC hypertrophy after
creation of aorta-caval shunt for 3 days (Figure 7D).
Discussion
In this study, we demonstrated several significant or novel
findings. Firstly, cyclic stretch upregulates myocardin
expression in rat VSMCs; secondly, cyclic stretch induces
AngII expression in VSMCs; thirdly, AngII acts as an
autocrine factor to mediate the increased myocardin
expression induced by cyclic stretch; fourthly, ERK MAP
kinase and SRF transcriptional factor are involved in the
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Figure 5 Effect of stretch on the migration of myocardin in VSMCs. (A) Condition medium (CM) was obtained from VSMCs after cyclic
stretch for 24 h. VSMCs migrating through the filter were stained. (B) The stained VSMCs were counted in four fields under a 400 X high-power
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Figure 6 Protein synthesis in VSMCs increases after cyclic stretch. Incorporation of 3H-proline into VSMCs in condition medium (CM)
increased after 20% cyclic stretch and exogenous addition of AngII for 12 to 24 hrs and was suppressed by PD98059, losartan, AngII antibody,
and myocardin siRNA. *P < 0.05 vs. control. #P < 0.05 vs. cyclic stretch (n = 6 per group).










Figure 7 Cyclic stretch and aorta-caval shunt induce VSMC
hypertrophy. Confocal microscopy showed increased VSMC size
24 hr after cyclic stretch, which represented a hypertrophic change
of VSMCs (Figure 7B). In addition, VSMC hypertrophy was also noted
after creation of aorta-caval shunt for 3 days (Figure 7D).
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myocardin expression. Myocardin was upregulated in both
a time- and load- dependent manner by cyclic stretch.
Cyclic stretch of VSMCs increased both myocardin
protein and mRNA expression.
In our study, exogenous addition of AngII to non-
stretched VSMCs was also sufficient to induce similar
myocardin protein expression as that observed in stretched
VSMCs. These results provide the first evidence that AngII
mediates cyclic stretch-induced expression of myocardin in
VSMCs. Our study revealed that AngII acts as an autocrine
mediator in response to cyclic stretch in VSMCs. Pre-
viously, another study identified that AngII enhanced
myocardin expression through AngII type 1 (AT1) receptor
results in VSMC hypertrophy [12]. We also have previously
demonstrated that hypoxia in cardiomyocytes increased
AngII secretion and myocardin expression and finally
resulted in cardiac myocyte hypertrophy through the ERK
pathway [13]. In this study, we found that cyclic stretch
also enhanced myocardin expression by AngII secretion
and the ERK pathway, which had not been identified by
previous studies.
However, one study found no increased concentration
of AngII in the medium collected from porcine VSMCsat 24 and 48 h after 25% stretch [36]. Sotoudeh et al.
used pulmonary VSMCs, whereas our study used rat
aortic VSMCs. Different species, stretch intension, and
stretch time may explain the discrepancy. Our results
suggest that AngII is responsible for myocardin-DNA
binding in VSMCs. In this study, we demonstrated that
cyclic stretch stimulation of myocardin-DNA binding
activity required at least phosphorylation of ERK since
ERK pathway inhibitor (PD98059) and ERK siRNA
abolished the myocardin/SRF binding activity. PD98059,
a potent and specific inhibitor of ERK MAP kinase, also
inhibited the myocardin expression induced by stretch,
whereas inhibitors of p42/p44, p38, and c-JUN MAP
kinase did not have this inhibitory effect. Thus, ERK
MAP kinase is an important intracellular signaling path-
way that regulates myocardin expression. We also
demonstrated that ERK siRNA significantly inhibited
myocardin expression induced by stretch. ARB likewise
had an inhibitory effect on the stretch-induced myocardin
expression. Since ARB is an AngII inhibitor, and mecha-
nical stretch is known to affect the production of AngII,
[37], our findings potentially indicate that AngII has a role
in the induction of myocardin by mechanical stretch. In
this study, we demonstrated via promoter activity assay
that increased transcriptional activity of myocardin pro-
moter by cyclic stretch was SRF dependent. These data
imply that the ERK MAP kinase pathway, but not the
other MAP kinase pathway, is the major pathway involved
in the induction of myocardin by stretch and that it
mediates the increased binding activity of myocardin and
transcription to VSMCs.
Mechanical stretch can modulate several different
cellular functions in VSMCs. These functions include
cell alignment and differentiation, migration, survival or
apoptosis, vascular remodeling, and autocrine or para-
crine functions [37]. However, use of different kinds of
VSMCs (venous or arterial) and various species of
animals used in different studies (mouse, rat, rabbit,
swine and others), have resulted in sometimes contro-
versial findings [37]. Most of these studies used in vitro
models. However, the cellular functions induced by
in vitro mechanical stretch may not accurately represent
cellular function in vivo [37]. So, more studies are neces-
sary to identify the real effects of mechanical stretch on
VSMC functions and the mechanisms by which they
occurr. Our study further confirmed the increased aortic
myocardin expression in acute hemodynamic overload
as that occurring with aorta-caval shunts. It has been
previously reported that myocardin protein expression
increased in the carotid artery balloon injury model in
rats [11], suggesting myocardin may be enhanced during
acute hemodynamic overload in vivo. The increased
myocardin protein expression following acute hemo-
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Figure 8 Effect of in vivo model of aorta-caval shunt (AV shunt) on aortic myocardin protein levels. (A) Western blots for myocardin in
rat aorta after short-term induction of AV shunt. (B) Quantitative analysis of myocardin protein levels. The values have been normalized to GAPDH
measurement and then expressed as a ratio of normalized values to myocardin protein in sham. (C and D) Treatment with losartan (10 mg/kg/day)
throughout day 1 to day 5 after performing aorta-caval shunt signigicantly suppressed myocardin protein expression from day 1 to day 3. *P < 0.01 vs.
control. #P < 0.05 vs. 24 h (n = 5).
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proliferation [17].
With regard to the clinical application of cyclic stretch
on VSMCs, mechanical stretch activates multiple intra-
cellular signaling networks and regulates gene expres-
sions and functional responses in VSMCs. The cellular
and molecular effects of mechanical stretch on vascular
cells may provide new insights in the pathogenesis of
vascular diseases and therapeutic potentials. Mechanical
stretch can modulate several different cellular functions
in VSMCs, including cell alignment and differentiation,
migration, survival or apoptosis, vascular remodeling,
and autocrine and paracrine functions. Arterial VSMCs
are aligned primarily in the circumferential direction in
the media of the artery. Mechanical stretch from pulsa-
tile blood flow is one of the key factors in regulating
vascular remodeling. VSMC migration is important in
the development of vascular diseases, including atheros-
clerosis and post-angioplasty restenosis. VSMC migra-
tion is found more frequently in curved and bifurcating
blood vessels, which are exposed to non-laminar blood
flow, than in straight arterial segments exposed to la-
minar blood flow. In this, we have also demonstratedthat mechanical stretch increased the migration of
VSMCs. The gene expression induced by mechanical
stretch may be relevant to pathological complications in
the cardiovascular system, including atherosclerosis,
plaque instability and hypertension. The induction of
genes by mechanical stretch may play a role in vascular
remodeling. Understanding the molecular mechanisms
regulating VSMC remodeling, migration, and prolifera-
tion under mechanical stretch supports the clinical
application of ACEI (angiotensin-converting enzyme in-
hibitors), ARB, and statin in cardiac protection and in
the prevention of vascular diseases. Therefore knowledge
of the impact of mechanical stretch on VSMCs is vital in
the understanding of the pathogenesis of cardiovascular
diseases and is crucial in providing new insights into the
prevention and therapy of cardiovascular diseases.Conclusion
In summary, our study reports for the first time that cyclic
mechanical stretch enhances myocardin expression in
cultured rat VSMCs. The stretch-induced myocardin is
mediated by AngII through the ERK pathway.
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